Transcat (NASDAQ:TRNS) Reaches New 1-Year Low – Time to Sell?

Transcat, Inc. (NASDAQ:TRNS) shares reached a new 52-week low on Tuesday . The stock traded as low as $80.30 and last traded at $82.34, with a volume of 33464 shares traded. The stock had previously closed at $99.13.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Oppenheimer restated an “outperform” rating and issued a $130.00 target price (down from $155.00) on shares of Transcat in a report on Wednesday, October 30th. HC Wainwright reissued a “buy” rating and issued a $156.00 price objective on shares of Transcat in a research note on Tuesday, October 29th. Craig Hallum boosted their price objective on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Northland Securities decreased their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th. Finally, StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $130.25.

Transcat Stock Performance

The business has a fifty day simple moving average of $105.34 and a 200-day simple moving average of $115.41. The firm has a market cap of $694.65 million, a price-to-earnings ratio of 39.02 and a beta of 0.71.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.36% and a net margin of 6.63%. During the same period last year, the firm posted $0.56 EPS. On average, equities analysts anticipate that Transcat, Inc. will post 2.44 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in TRNS. nVerses Capital LLC bought a new position in Transcat in the third quarter worth approximately $60,000. SG Americas Securities LLC purchased a new stake in shares of Transcat during the fourth quarter valued at approximately $182,000. US Bancorp DE increased its position in shares of Transcat by 15.6% during the third quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after acquiring an additional 209 shares during the last quarter. Captrust Financial Advisors purchased a new stake in shares of Transcat during the third quarter valued at approximately $201,000. Finally, Walleye Capital LLC purchased a new stake in Transcat in the third quarter worth $216,000. Institutional investors own 98.34% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.